Genetech Inc’s (Human Growth Hormone) Patent: 1989

The court considered an enabling disclosure: ‘ . . what has come to be called an ‘enabling disclosure’, that is to say, one sufficient, in the case of a claim to a chemical compound, to enable those skilled in the art to make the compound claimed’

Judges:

Falconer J

Citations:

[1989] RPC 613

Jurisdiction:

England and Wales

Cited by:

ApprovedAsahi Kasei Kogyo KK’s Application HL 1991
The House considered a case involving the issue of enablement of a particular peptide in a patent application.
Held: On the assumed facts that there had been a prior disclosure of the same invention neither the disclosed information nor common . .
CitedSynthon Bv v Smithkline Beecham Plc HL 20-Oct-2005
Synthon filed an international application for a patent. Before it was published, SB filed a similar application in the UK patents registry. Synthon had applied for the UK patent granted to SB to be revoked. Jacob J had found that the reader of the . .
Lists of cited by and citing cases may be incomplete.

Intellectual Property

Updated: 07 December 2022; Ref: scu.231509